Neurotech International Ltd.ASX: NTI

Phase II/III ASD Trial Successfully Meets Primary Endpoint

Apr 17, 2024 at 4:11 AM UTC · Issued by Neurotech International Ltd.

Neurotech International Ltd has released a press release.

View Attachment